CorMedix Inc. - 8-K Filing

CorMedix Inc. hosts investor webcast regarding Q3 2026 financial results and provides updates on proposed acquisition of Heron Therapeutics assets. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CRMD

Read the full article at SEC EDGAR

Part of the story ENERGY FUELS INC - 8-K Filing (3 articles)

More Regulatory news